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Protein glycosylation is essential to trafficking and immune
functions of human neutrophils. During granulopoiesis in the
bone marrow, distinct neutrophil granules are successively
formed. Distinct receptors and effector proteins, many of which
are glycosylated, are targeted to each type of granule according
to their time of expression, a process called “targeting by tim-
ing.” Therefore, these granules are time capsules reflecting dif-
ferent times of maturation that can be used to understand the
glycosylation process during granulopoiesis. Herein, neutrophil
subcellular granules were fractionated by Percoll density gradi-
ent centrifugation, and N- and O-glycans present in each com-
partment were analyzed by LC–MS. We found abundant
paucimannosidic N-glycans and lack of O-glycans in the early-
formed azurophil granules, whereas the later-formed specific
and gelatinase granules and secretory vesicles contained com-
plex N- and O-glycans with remarkably elongated N-acetyllac-
tosamine repeats with Lewis epitopes. Immunoblotting and
histochemical analysis confirmed the expression of Lewis X and
sialyl-Lewis X in the intracellular granules and on the cell sur-
face, respectively. Many glycans identified are unique to neutro-
phils, and their complexity increased progressively from
azurophil granules to specific granules and then to gelatinase
granules, suggesting temporal changes in the glycosylation ma-
chinery indicative of “glycosylation by timing” during granulo-
poiesis. In summary, this comprehensive neutrophil granule
glycome map, the first of its kind, highlights novel granule-spe-
cific glycosylation features and is a crucial first step toward a
better understanding of the mechanisms regulating protein gly-
cosylation during neutrophil granulopoiesis and amore detailed
understanding of neutrophil biology and function.
Neutrophils are central cells of innate immunity, primarily
dedicated to the killing of invading microbes. They are nondi-
viding, short-lived white blood cells that, in large numbers and
with impressive specificity, can perform numerous functions. It
is well-established that mature neutrophils in circulation con-
tain different granule subsets that harbor distinct proteins and
other biomolecules (1, 2). Sequential mobilization of granules
allows for the cells to rapidly change their surface receptor rep-
ertoire and release matrix-destroying proteases to facilitate
transmigration from the blood, extravasation into infected and
inflamed tissues, and phagocytosis of microbes and cellular de-
bris. Therefore, a distinct separation of proteins between the
different granules and vesicles is important for neutrophils to
appropriately respond to inflammation and infection.
The neutrophil granules are sequentially formed during
granulopoiesis, the process of neutrophil maturation in the
bone marrow (1). Early during the promyelocyte stage, the
azurophil granules (AG) are formed, followed by the specific
and gelatinase granules (SG and GG), which develop sequen-
tially during the myelocyte/metamyelocyte and band cell
stages, respectively. Finally, the so-called secretory vesicles
(SV) are formed from the plasma membrane (PM) of mature
neutrophils through endocytosis. Because no subsequent
exchange of proteins between fully synthesized compart-
ments are thought to occur, the neutrophil proteins that are
synthesized during the different stages of granulopoiesis end
up in the corresponding granule type, a process known as
“targeting by timing.” This was elegantly exemplified in stud-
ies correlating transcriptomics and proteomic data of matur-
ing neutrophils and their granules, SV, and PM (1, 3, 4).
The majority of granule and cell surface proteins are glyco-
sylated (1). Glycosylation adds structural and functional het-
erogeneity to proteins by the attachment of oligosaccharides
to specific amino acid residues. The N-glycans are attached
to amino acid consensus sequences Asn-Xaa-Ser/Thr (where
Xaa = Pro), whereas O-glycans (mucin-type, O-GalNAc-type)
are attached to Ser and Thr. Specific glycan structures and/or
epitopes are involved in multiple aspects of the immune re-
sponse, including neutrophil function. The glycosylation of neu-
trophil proteins is diverse and functionally important for the
inflammatory response, e.g. by binding to immune regulating
lectins such as selectins, siglecs, galectins, C-type lectins, and
microbial adhesins (5–9).
Earlier MS studies documenting protein glycosylation in
whole intact neutrophils showed the presence of Galb1–
4GlcNAc, i.e. N-acetyllactosamine chains (LacNAc) linked to
lipids or protein (10, 11) and that some of the LacNAc moieties
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were modified with fucose and/or terminal sialic acid residues,
generating epitopes such as Lewis X (Lex; Galb1–4(Fuca1–3)
GlcNAcb-R) and sialyl-Lewis X (sLex; Neu5Aca2–3Galb1–4
(Fuca1–3)GlcNAcb-R). These epitopes are the main ligands of
the endothelial selectins involved in neutrophil capture and
rolling on the endothelium, enabling transmigration to the pe-
ripheral tissue (12, 13). Deficiency in the sLex antigen presenta-
tion on the neutrophil cell surface causes leukocyte adhesion
deficiency 2, associated with recurrent infection, persistent leu-
kocytosis, and severe mental and growth retardation (14, 15).
The interest in the roles played by Lex and sLex antigens in cell
recruitment has resulted in more specific analyses of these neu-
trophil epitopes, on a subcellular level.
Detailed analyses of glycan structures of neutrophil granule
glycoproteins have been carried out (9, 16–18). Although glyco-
sylation is known to be essential to neutrophil function (12, 13,
19), a comprehensive mapping of the granule and cell surface
glycome is still lacking even of healthy resting (nonactivated)
neutrophils. Recently, we have identified paucimannosidic gly-
cans (Man1–3GlcNAc2Fuc0–1) carried by glycoproteins in the
sputum of cystic fibrosis patients (20). These glycoproteins
were traced back to the AG of human neutrophils (21), for
example, neutrophil elastase, where the unusually truncated
glycans were shown to influence the binding of elastase toman-
nose-binding lectin and A1-antitrypsin often present within
inflamed tissues (22).
Herein, we provide a comprehensive characterization of the
N- and O-glycans in neutrophil granules, isolated using subcel-
lular fractionation and analyzed by porous graphitized carbon
(PGC)–LC–MS/MS. We show vast differences in glycosylation
between different granules. By building on the targeting-by-
timing hypothesis, the granule-specific glycan differences
therefore suggest that the glycosylation machinery undergoes
alterations during granulopoiesis. The differences in glycosy-
lation between granules could impact the immune modulat-
ing functions of neutrophils during inflammation.
Results
The neutrophil subcellular organelles are characterized by
unique N-glycan signatures
Subcellular organelles of healthy resting neutrophils were
first separated by two-layer Percoll gradients into three frac-
tions; AG, SG 1 GG, and SV 1 PM (Fig. 1a). Organelle lysis
and extraction and solubilization of organelle proteins were fol-
lowed by enzymatic release of N-glycans, and MS analyses
Figure 1. Validation of neutrophil subcellular fractionation and organelle-specific neutrophil N-glycan profiling. a, the granules of naive (resting) neu-
trophils were fractionated using a two-layer Percoll gradient. Fractions were assigned to distinct neutrophil organelles based on the level of known granule-
specific protein markers as determined using immunoblot and activity assays (y axis, arbitrary units, A.U.): MPO activity (marker for AG, filled squares); LF
(marker for SG, filled diamonds); and total ALP activity (measured in the presence of detergent; marker for SV1 PM, filled circles). The data shown are represen-
tative from three separate, independent experiments. b, mass spectral profiles of N-glycans released from neutrophil granule protein extracts showing dra-
matic qualitative N-glycan profile differences between the AG, SG1 GG, and SV1 PM fractions. Characteristic N-glycan types for each granule fraction have
been color-coded to highlight the most prominent differences. c, distribution of the identified N-glycan structures in the different neutrophil subcellular com-
partments. d, theN-glycans identified in the different subcellular fractions were grouped into themajorN-glycan types, i.e. paucimannosidic, oligomannosidic,
and complex N-glycans and their relative abundance were determined for each granule subset. The data points are plotted as themean6 S.E. (n = 3).
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enabled the unambiguous identification of 69 unique N-gly-
cans. The obtained profiles between the three fractions differed
vastly from each other (Fig. 1b). Paucimannosidic and complex
N-glycans were predominantly identified in AG and SG1 GG,
respectively, whereas SV 1 PM contained oligomannose and
complex glycans, at similar levels (40–50%). The analysis iden-
tified 36 N-glycans in AG, 60 in SG1 GG, and 61 in SV1 PM.
Of the total 69N-glycans, 27 were present in all organelles, and
SG1 GG and SV1 PM were mostly similar, sharing 50 N-gly-
cans (Fig. 1c). These qualitative differences were corroborated
also on the quantitative level (Fig. 1d). Hence, the different or-
ganelles all had unique sets of glycan structures that were in
some parts overlapping. The detailed list ofN-glycans and their
relative abundances in each fraction is found in Table S1.
Paucimannosidic and oligomannosidic-type N-glycans are
abundant on proteins in the AG and SV1 PM, respectively
The hallmark of AG was the presence of paucimannosidic
glycans, with a relative abundance of 49.4 6 5.8% of all N-gly-
cans. In contrast, only 18.76 5.2% and 4.96 0.9%, respectively,
of all N-glycans were paucimannosidic in SG 1 GG and SV 1
PM (Fig. 1d). Six different paucimannosidic glycans were iden-
tified in AG, with themost abundant (65% of the paucimannose
glycans) containing twomannoses and a core fucose (M2F;m/z
895.312) (Fig. 2a and Fig. S1). In fact, within the class of pauci-
mannosidic-type N-glycans, the M2F was clearly the most
abundant paucimannosidic glycan species in all organelles (Fig.
2a), but the overall abundance of M2F in SV 1 PM and SG 1
GG was ,5% of total N-glycans as compared with 40% in the
AG. Only the a1,6-isomer of the M2F glycan was observed in
agreement with our previous reports (21, 22). Another striking
feature of AG is the high abundance of core fucosylation
(80.4%) as compared with antenna fucosylation (19.6%).
Oligomannose and complex type N-glycans predominate in
the SV 1 PM fraction, with a relative abundance of 46.1 6 3.7%
and 49.1 6 3.2%, respectively (Fig. 1, b and d). Oligomannose
N-glycans in the SV 1 PM fraction showed low abundance of
Man4 glycan and a varied distribution of Man5 to Man9 glycans
(Fig. 2b). Oligomannose glycans were present also in AG and
SG1 GG, however at much lower levels (9.76 0.7% and 19.96
4.2%, respectively). The distribution between Man4 to Man9
glycans was similar in these organelles as in SV1 PM (Fig. 2b).
Complex N-glycans with LacNAc repeats are characteristic of
the SG1 GG and SV1 PM
Complex N-glycans were observed in all fractions, with a
higher abundance in the SG 1 GG (61.4 6 9.5% of all N-gly-
cans) as compared with the AG (40.7 6 6.5%) and SV 1 PM
(49.1 6 3.2%) (Fig. 1d). Conventional glycans carrying single
LacNAcs on both antennae were observed in AG, albeit in
lower abundance (5.86 1.8%) as compared with the other frac-
tions. In contrast, one of the key glycosylation features in SG1
GG and SV1 PM was the presence of unusual, very-high-mo-
lecular-mass complex glycans extended with repeating LacNAc
units (Fig. 3a). Because these glycans were characterized by
broad peaks of extracted precursor ions caused by unresolved
multiple isomers, their abundances were not considered during
our initial analysis.
Apart from oligomannose structures, the glycan profile of SV
1 PMwas similar to that of the SG1 GG with elongated com-
plex N-glycans (Fig. S2). In SG1 GG, complex-type N-glycans
were predominantly biantennary fucosylated glycans with or
without terminal sialic acid. The most abundant glycan (m/z
1111.922) identified in SG1 GGwas a biantennary monosialy-
lated and difucosylated glycan with both core and a single
antenna fucosylation (Fig. 3a). The identified sialylated glycans
were found to be mainly a2,6 linked to galactose on the 39 arm
and a2,3 linked forming sLex on the 69 arm. In conclusion,
complex N-glycans with LacNAc repeats were abundant in
SG1GG and SV1 PMbut absent fromAG.
The LacNAc repeats are mainly found on biantennary N-
glycans
The structures of the extended LacNAcs were confirmed
based on their composition related to their molecular mass,
along with supporting PGC–LC retention time data and MS/
MS spectral data that concertedly were able to confirm the
sequence and branch points of the extended structures. Spectra
were manually annotated for B-/Y- and C-/Z- ion series as well
as diagnostic ions for various glycoepitopes (23). A representa-
tive MS/MS fragmentation of a four-LacNAc-containing gly-
can atm/z 155022 is shown in Fig. 3b. The presence of various
fragment ions, including m/z 1039.522, 1213.222, 1294.822,
1469.022, 1713.412, and 1917.412 and D-ions of 1692.412 and
1710.412, suggests exclusive elongation of 69 arm rather than 39
arm elongation (24, 25) and as opposed to branched tri- or
Figure 2. Distribution of mannose-terminating N-glycans in AG and SV1 PM. a and b, relative abundance of the observed paucimannosidic (a) and oli-
gomannose (b) N-glycans in AG, SG 1 GG, and SV 1 PM fractions. The relative distribution of N-glycans is plotted as the mean 6 S.E. (n = 3). Blue squares,
GlcNAc; green circles, mannose; red triangles, fucose.
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tetra-antennary glycans. These fragment ions were observed in
the MS/MS fragmentation spectra of other glycans as well (Fig.
S3), which support and confirm our assessment. Furthermore,
the monosaccharide composition of glycans with additional
LacNAc repeats contains either one or two terminal sialic acids,
supporting the presence of elongated biantennary glycans
instead of higher branched glycans. Broad signal peaks of
higherm/z values suggest that tri- and tetra-antennary glycans
elongated with LacNAc units may also be present but at a lower
abundance.
Information about the degree of LacNAc extensions could
be obtained from the combined intensities of the broad LC
peaks, which corresponds to structures potentially carrying
three to ten LacNAc units (Fig. S4, top panel). It could be
seen that structures containing six to eight LacNAc units
were the most abundant in both SG 1 GG and SV 1 PM.
Simple extrapolation of the data suggests that structures
even longer than 10 LacNAc units could be present in both
of these fractions, but they were due to structural ambiguity
not included here.
The unusually long LacNAc repeats of SG1 GG and SV1 PM
are decorated with Lewis epitopes
Fucosylation of the GlcNAc moiety in the LacNAc chains,
building Lewis type epitopes, was observed in the SG 1 GG
and SV1 PM fractions. It should be noted that not all LacNAcs
in an antenna were fucosylated. For the high-molecular-
mass glycans, we calculated the number of Lewis epitopes
per structure and their corresponding relative intensities
(Fig. S4, bottom panel). Simple structures containing one to
three Lewis epitopes were more abundant than structures
containing higher numbers of fucose. Structures were found
to be decorated with a maximum of seven fucose residues.
The data also show that the amount of fucosylation per Lac-
NAc was decreasing with the increasing number of Lewis
epitopes.
When analyzing the fractions for Le epitopes by immuno-
blotting analyses, the Lex antigens were mainly found in the SG
1 GG fraction, whereas sLex epitopes were detected predomi-
nantly in the SV 1 PM fraction (Fig. 3c). Using confocal mi-
croscopy, the presence of Lex was detected in intracellular gran-
ules, whereas sLex was mainly localized to vesicles close to the
cytoplasmic membrane, suggesting that sLex is carried by gly-
cans that are associated with the SV 1 PM (Fig. 3d). Overall,
these data show that neutrophils extensively express complex
N-glycans with elongated LacNAc repeats that are decorated
with fucose (Lex; in SG 1 GG) and capped with sialic acid
(sLex; in SV1 PM).
Gelatinase granule proteins carry N-glycans with higher
numbers of LacNAc repeats than specific granules
Using crude granule separation, the above have demon-
strated that the neutrophil granules, in addition to their differ-
ence in size, density, and protein composition, also differs in
their glycan composition (Fig. 1, b and d) (3, 26) and indicated
some peculiar N-glycosylation features in the SG 1 GG frac-
tion. We wanted to investigate the granule-specific glycosyla-
tion further using a higher resolution granule separation tech-
nique. The SG and GG fractions were separated using a three-
layer Percoll gradient (Fig. 4a) and analyzed for high molecular
massN-glycans.
Mass spectra of the N-glycans in the m/z 1200–2000 region
revealed an enrichment of triply charged ions in the GG,
whereas doubly charged ions were more abundant in the SG
(Fig. 4b). It is important to note that the detection of more
high-molecular-mass glycans in the isolated GG fraction
(three-layer gradient) as compared with in the combined SG1
GG fraction (two-layer gradient) is a consequence of absence of
SG in the GG fraction. Consequently, the precursor ion (m/z
1933.732) corresponding to eleven LacNAcs, four fucoses,
and one sialic acid (Dmassof  0:016DaÞ, the longest glycan
detected, was identified only in the GG fraction of the three-
layer gradient.
The relative intensities of glycans, based on their predicted
monosaccharide compositions, were grouped into different
mass ranges. It is evident that the relative intensities of glycans
containing five to eight LacNAcs per structure were more
abundant in SG as compared with GG (Fig. 4c). In contrast,
structures containing nine or more LacNAcs were more abun-
dant in the GG fraction. Taken together, the data strongly sug-
gest that the glycans in GG are further elongated and larger
than those in the SG.
The glycan types are differently distributed between the
membrane and luminal protein extracts
The glycans identified in the granule fractions may originate
either from the granule membrane or luminal (i.e. soluble) pro-
teins. For SV, the lumen contains plasma proteins taken up
during invagination of the plasmamembrane during neutrophil
terminal differentiation (27). To address which of the identified
glycans are displayed on membrane-associated proteins, the
membrane protein extracts were separated from the soluble
protein extracts for each granule population (AG, SG, and GG)
and the SV1 PMobtained from the three-layered Percoll isola-
tion method. Paucimannosidic glycans were enriched in the
AGmembrane protein fraction, whereas oligomannose glycans
were enriched in the membrane fraction of SG and SV 1 PM
(Fig. 5). In contrast, complex glycans were observed in high
abundance on the soluble protein fraction in all granules.
Figure 3. Unusual LacNAc-elongated complex N-glycans reside in the SG and GG fractions. a, representative mass spectral profile of SG1 GG N-glycans
illustrating the presence of unusual LacNAc-elongated N-glycans, up to 10 repeats, with and without fucose and/or sialic acid capping, forming Lewis epi-
topes. b, N-glycans were characterized using CID–MS/MS in negative polarity as exemplified by the annotated MS/MS fragmentation spectrum of the precur-
sor ionm/z 155022 corresponding to an N-glycan containing four LacNAc units with fucosyl and sialyl decorations. Diagnostic ions confirmed the presence of
LacNAc elongation as opposed to antenna branching. c, immunoblot analysis of Lex and sLex epitopes on proteins from different organelles. Equal protein
amounts were loaded for each fraction as determined by BCA assay. d, representative images of immunofluorescence-stained neutrophils demonstrating the
localization of Lex (left panel) and sLex (right panel) epitopes. Scale bar, 5 mm. Blue squares, GlcNAc; green circles, mannose; red triangles, fucose; yellow circles,
galactose; purple diamonds, sialic acid (N-acetylneuraminic acid).
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O-Glycans are absent in AG, whereas extended LacNAc-rich
core 2 O-glycans are consistently found in the other
fractions
Apart from N-glycan analysis, proteins were also sub-
jected to reductive b-elimination, after which the released
O-glycans were analyzed. Notably, no O-glycans were de-
tected in the AG, whereas SG 1 GG (Fig. 6a) and SV 1 PM
(Fig. S5) demonstrated the presence of similar O-glycans,
with a total of 17 O-glycans identified. The most abundant
O-glycans were mono- and disialylated core 1 and core 2
glycans (Fig. 6a). Analogous to the LacNAc extension of the
N-glycans, only one of the branches was elongated with Lac-
NAcs on O-glycans. Sialic acid linked to galactose was found
on the 39 arm but not on the 69 arm, whereas the fucose moi-
ety was located on the 69 arm together with LacNAc exten-
sions as elucidated using molecular mass, PGC–LC reten-
tion time, and MS/MS fragmentation (Fig. 6b). Similar to
N-glycans, O-glycans with Lex epitopes were identified, with
fucosylation on 69 arm and sialylation capping on the other
arm (Fig. 6b). In conclusion, neutrophil granule proteins are
modified with core 1 and core 2 O-glycans carrying LacNAc
chains and Lex antigens, whereas sLex epitopes were not
commonly observed.
Granule glycosylation during granulopoiesis
Different granules are sequentially formed at different stages
during granulopoiesis: myeloblasts or promyelocytes (AG),
myelocytes/metamyelocytes (SG), and band cell stage (GG).
The quantitative comparison of the glycan composition
revealed a shift from paucimannosidic N-glycans and a lack of
O-glycans in the AG to LacNAc-containing complex glycans in
the SG and GG (Fig. 7). This suggests a change in glycosylation
machinery over time during granulopoiesis. We therefore com-
pared the glycomic data with the correspondingmRNA expres-
sion profiles (from the publicly available Bloodspot database
(28)) of enzymes responsible for glycan synthesis during granu-
lopoiesis. We noticed a higher expression of HEXA encoding
the N-acetyl-b-hexosaminidase subunit a, responsible for the
formation of paucimannosidic glycans (21, 29), in promyelo-
cytes as compared with cells from later stages of granulopoiesis
(Fig. S6). In contrast, expression of B3GNT3 (GlcNAc transfer-
ase), B4GALT4 (galactosyl transferase), and FUT3 (fucosyl
transferase), encoding glycosyltransferases responsible for the
synthesis of LacNAc repeats and Lex, was expressed at higher
levels in the later maturation stages as compared with the early
maturation stage (28). Finally, ST3GAL4 encoding a sialyl
transferase responsible for synthesizing sLex was found to be
Figure 4. The elongation length of LacNAc-containing N-glycans differs in the SG and GG. a, the granules of naive neutrophils were fractionated
using a three-layer Percoll gradient. Fractions were assigned to distinct neutrophil granule fractions based on the level of known granule-specific pro-
tein markers as determined using immunoblots and activity assays (y axis, arbitrary units, A.U.): MPO activity (marker for AG, filled squares); LF (marker
for SG, filled diamonds); MMP9 (marker for GG, open diamonds); and total ALP activity (measured in the presence of detergent; marker for SV 1 PM,
filled circles). The data are representative of three separate, independent experiments. The bars indicate which fraction numbers were pooled together
for the glycan analysis. b, representative mass spectra focusing on the highm/z region encompassing the elongated LacNAc repeat–containing N-gly-
cans released from SG (top panel) and GG (bottom panel) protein extracts, respectively. Them/z values underlined in green and red indicate doubly and
triply charged ions, respectively. Many triply charged glycans found in the GG spectrum are either low in abundance or absent in the SG spectrum,
indicated by the red dashed arrows. c, the relative intensities of glycan structures identified in SG and GG (based on predicted monosaccharide compo-
sitions) and divided into different mass ranges, showing that the GG have more glycans of higher mass than the SG. The number of potential LacNAcs
in each mass range is shown.
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expressed predominantly during the final stages of maturation
(28). In conclusion, the glycomic data together with database-
mined mRNA expression data support our hypothesis that a
change in the glycosylation machinery occurs over time during
granulopoiesis.
Discussion
Defining molecular differences between neutrophil organ-
elles, proteins, and finally their glycosylation, is a prerequisite
for better understanding neutrophil biology and function.
Mapping of the protein composition of neutrophil subcellular
organelles (3, 26), as well as their gene and protein expression
during granulopoiesis (4, 30–32), has provided a comprehen-
sive qualitative and quantitative basis for the targeting-by-tim-
ing hypothesis, which appears to accurately describe the evolu-
tion of neutrophil protein composition over time during
granulopoiesis. This work provides a platform on which matu-
ration-associated post-translational modifications, not least
glycosylation, can be studied. We have, as a first, characterized
the N- and O-glycans in neutrophil granules, as well as in the
SV/PM using a PGC–LC–MS/MS-based glycomics approach
recognized for providing information of the glycan fine struc-
tures while also giving quantitative information at high sensitiv-
ity (33, 34).
The characteristic feature of the AG glycoproteins is the
presence of paucimannosidic type N-glycans and the absence
of O-glycans. Our developing knowledge of protein pauciman-
nosylation in human biology including aspects covering its
structure, function, and tissue expression has recently been
extensively summarized (29). Sequential trimming of the glyco-
protein intermediate, i.e. b1,2-GlcNAc–capped trimannosyl-
chitobiose core with or without core fucose by Hex A and/or
Hex B, and presumably a linkage-specific A-mannosidase gives
rise to paucimannosidic glycans of which one species (the A1,6-
isomer of M2F) represents.60% of the total amount of pauci-
mannose. This was supported by a strong co-localization of
Hex A and myeloperoxidase (MPO) in differentiated HL-60
cells using immunohistochemistry (21).
Upon inflammation in vivo, the AG proteins carrying pauci-
mannosidic glycans are released or leak from activated neutro-
phils as a result of substantial cell activation or cell death. These
encompass an ensemble of bioactive AG proteins, including
MPO, neutrophil elastase, and other serine proteases (21, 22,
35, 36). The structure–function relationship of the pauciman-
nosidic glycans, modulating the proinflammatory effects of
these proteins, can at this point only be speculated upon, but
both paucimannosidic and oligomannosidic-type N-glycans
have been shown to bind to mannose recognizing C-type lectin
receptors expressed by macrophages and dendritic cells (22, 37,
38). Also, the macrophage mannose-receptor has been shown
to internalize neutrophil-derived MPO (39), playing a potential
physiological role in regulating extracellular MPO levels.
Although the preference of the mannose-receptor for specific
glycan substrates has yet to be documented in neutrophils, the
structures and localization in the various granule compart-
ments identified here will be useful for future investigation.
Abundance of complexN- andO-glycans with extended Lac-
NAc chains was a characteristic feature observed in the SG 1
GG, formed during the middle stages of granulopoiesis. The
level of LacNAc chains identified are unique to neutrophils and
Figure 5. The N-glycan signatures differ on soluble (luminal) and membrane proteins in the different neutrophil organelles. Quantitative glycomics
was performed for N-glycans released from separated membrane and lumen (soluble) protein extracts from isolated neutrophil granules and SV 1 PM. The
identified glycans have been grouped and quantified according to their N-glycan type, i.e. paucimannosidic, oligomannosidic, and complex N-glycans. Note
that the glycans from the soluble proteins in the SV1 PM fraction are not of neutrophil origin but come from plasma proteins. The data represent the means
6 S.E., and unpaired two-way Student’s t test was used for statistical analysis. *, p, 0.05; **, p, 0.01; ***, p, 0.001; ****, p, 0.0001.
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have to our knowledge never been reported in other immune
cells. In fact, the number of LacNAc repeats reported here is
probably underestimated, because we incidentally identified
structures with up to 16 LacNAcs in few of the spectra and the
fact that the LC–MS/MS approach inherently favors the
shorter structures. Given that the complex glycans in the SG,
GG, and SV1 PM fractions are mostly biantennary, these long
LacNAc extensions placed close together on a cell surface could
build a dense net for interactions with lectins, e.g. galactose-
binding lectins such as galectins. In the context of neutrophil
function and regulation, carbohydrate-dependent binding of
galectin-3 can mediate cell adhesion, phagocytosis, and activa-
tion of the respiratory burst (40, 41). Interestingly, a prerequi-
site for the neutrophil response to galectin-3 is that the cells
first are primed by an inflammatory stimulus and have mobi-
lized the GG and SG, thereby having up-regulated granule-
stored, LacNAc-bearing protein receptors to the cell surface for
interactions with galectin-3 (42).
The LacNAc chain length may be biologically important in
this context, as shown by a galectin-3 mutant carrying
increased affinity for extended LacNAc structures, resulting in
an enhanced respiratory burst response in primed neutrophils
as compared with WT galectin-3 (43). Furthermore, the Lac-
NAc chains in the SG, GG, and SV1 PM were decorated with
fucose and sialic acid residues, forming Lewis epitopes at the
nonreducing end of N- and O-glycans. In addition to the well-
characterized role of Lex and sLex in cell adhesion, cell priming,
and phagocytosis (12, 19, 44, 45), the expression of Lea epitopes
on neutrophils has recently been shown to enhance neutrophil
transmigration and to play a role in regulating inflammation
(46). Although we believe that the sialyl-Lewis epitopes identi-
fied in this study were predominantly sLex (Fig. 3, c and d), the
presence of sLea especially on elongated structures needs to be
explored.
Unlike AG and SG 1 GG, which are enriched in pauciman-
nosidic and complex N-glycans, respectively, the SV 1 PM
Figure 6. Dominant core 2 O-glycosylation in SG and GG fractions. a, core 2 O-glycans were commonly observed with LacNAc extensions on the 69 arm
and sialic acid capping on the 39 arm galactose in SG1 GG fractions. b, LC–MS/MS spectra of core 2 O-glycan (m/z 118612) with sialic acid capping on the 39
arm and Lewis epitope on the 69 arm. Asterisks represent contaminating signals of unknown origin. Blue squares, GlcNAc; yellow squares, GalNAc; red triangles,
fucose; yellow circle, galactose; purple diamonds, sialic acid (N-acetylneuraminic acid).
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fraction contains both oligomannose and processed complex
glycans. Although the soluble protein fraction of SV1 PM car-
ries proteins of non-neutrophil origin (i.e. plasma proteins
invaginated into the SV (27)), the granule membrane protein
glycosylation is of neutrophil origin. The SV1 PM membrane
fraction was predominantly composed of oligomannose glycans
that are readily available recognition tags on the cell surface of
resting or slightly primed cells (having mobilized the secretory
vesicles) (38). Indeed, a historically well-known mannose-de-
pendent interaction is that of the bacterial mannose-binding
adhesin FimH, which recognizes several mannose structures on
cell surfaces (47), mediating bacterial binding and phagocytosis
(48).
Biosynthetically, protein synthesis and granule targeting are
best described by the targeting-by-timing hypothesis, in which
proteins synthesized at the same time during granulopoiesis end
up in the same granules. How glycosylation fits into such a
scheme is an interesting question with implications for cell regu-
lation and function. Our data show distinct patterns of glycosyla-
tion for the different granules and organelles, and close analysis
of thesemolecular features provides important insights; the gran-
ule-specific glycans and corresponding mRNA expression of
enzymes responsible for glycan synthesis appear to co-emerge at
different stages of granulopoiesis, which suggests a change in gly-
cosylation machinery over time. The plasma membrane, which
contains both unprocessed oligomannose and processed complex
type glycans, is not formed within a defined time interval during
neutrophil differentiation, as the granules are. This is in line with
the fact that PM proteins are successively being modified with
the glycans specific to each different developmental stage during
granulopoiesis and are sorted to the cell surface. This results in
the presence of oligomannose type glycans potentially produced
during early stages of granulopoiesis, together with differently
matured poly-LacNAc–containing glycans produced later on.
The PM-targeted glycans will then be endocytosed and incorpo-
rated into the membranes of the SV during the final stages of cell
maturation.
To this background, it is tempting to suggest that a protein
synthesized at a certain time during granulopoiesis and tar-
geted to a certain granule subtype, is specifically modified with
a dedicated glycosylation pattern, synthesized at that same time
by a glycosylation machinery that is concurrently expressed.
Consequently, we have formulated a complementing hypothe-
sis to targeting-by-timing, stating that protein glycosylation
in neutrophils takes place through a “glycosylation-by-timing”
process (Fig. 7).
Furthermore, we suggest that the variation of glycosylation
during granulopoiesis may correlate to the evolution of the
Golgi complex, for which the size and number of stacks vary
greatly during granulopoiesis (49, 50), and/or the extensive gly-
can processing that may occur at different rates within the
formed granules during neutrophil maturation, directions that
we are currently pursuing. Also, the finding that the minute
amounts of elastase found outside of AG and SG appear to be
similarly glycosylated (22) may indicate that certain proteins (or
glycans) do not follow glycosylation by timing. We are currently
performing granular glycoproteomics to further investigate the
specific protein carriers of the neutrophil glycans, which will give
us better understanding of how protein glycosylation is evolving.
In conclusion, we provide a map of subcellular glycans in healthy
human neutrophils that displays peculiar granule-specific glycan
signatures, and this first-time mapping of neutrophil granule gly-
cans provides information on adaptations that may occur in the
glycosylationmachinery during granulopoiesis.
Materials and methods
Isolation of human neutrophils and subcellular fractionation
Human peripheral blood polymorphonuclear neutrophils
were isolated from buffy coats (The Blood Center, Sahlgrenska
University Hospital, Gothenburg, Sweden) obtained from
healthy donors (51). The erythrocytes were removed by dextran
(1%) sedimentation (1 3 g). Monocytes and lymphocytes were
removed by centrifugation on a Ficoll–Paque density gradient.
The cells were then washed in Krebs–Ringer phosphate buffer
Figure 7. Overviewof glycosylation-by-timing hypothesis.Granule formation during neutrophil maturation is a continuum, and granules carry a vast array
of glycans. From the presence of shorter paucimannosidic glycans in AG, to ever-elongating complex glycans in SG, and subsequently in GG and the corre-
sponding mRNA expression of different glycosidases and glycosyltransferases, suggests an evolution of granule glycosylation over time. Similar to the target-
ing-by-timing hypothesis describing the temporal protein synthesis of maturing neutrophils, we hypothesize a parallel glycosylation-by-timing granule
glycan synthesis that takes place during neutrophil maturation.
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containing glucose (10 mM) and Mg21 (1.5 mM), and the
remaining erythrocytes were removed by hypotonic lysis. These
purified neutrophils (.95% pure) were fractionated according
to Borregaard et al. (52). In short, 109 cells were treated with
the serine protease inhibitor diisopropylfluorophosphate (final
concentration, 8 mM), resuspended in 10ml of homogenization
buffer (100 mM KCl, 3 mM NaCl, 3.5 mM MgCl2, 10 mM PIPES,
pH 7.4) with 1mMATP(Na)2, 0.5mM phenylmethylsulfonyl flu-
oride and disrupted in a nitrogen bomb (Parr Instruments,
Moline, IL, USA) at 400 psi (2500 kPa). Intact cells and nuclei
were removed by successive centrifugation steps at 3003 g and
8003 g, respectively. The post nuclear supernatant was layered
on top of a two-layer (1.05 and 1.12 g/liter) or a three-layer
(1.05, 1.09 and 1.12 g/liter) Percoll gradient and centrifuged at
15,000 3 g for 45 min in a fixed-angle JA-20 Beckman rotor.
The material was typically collected in 25 fractions of 1.5 ml
(two-layer gradients) or 32 fractions of 1.0 ml (three-layer gra-
dients) from the bottom of the centrifuge tube.
Granule purity and fractionation
The distribution of four different, established markers
(MPO, marker for the AG; lactoferrin [LF], marker for the SG;
matrix metalloproteinase-9 [MMP9], marker for the GG; and
alkaline phosphatase [ALP], marker for the SV and PM) was
determined to establish the distribution of the different organ-
elles in the gradient. Enzyme activity of MPO and ALP, respec-
tively, was determined as previously described by Feuk-Lager-
stedt et al. (53). The LF andMMP9 distribution was assessed by
immunoblot using antibodies (anti-LF, Dako, rabbit polyclonal
antibody, 1/2500; anti-MMP9, Calbiochem, rabbit polyclonal
antibody 444236, 1/2000). When appropriate, fractions con-
taining the different organelles were pooled, diluted in homog-
enization buffer, and ultracentrifuged (100,0003 g, 1 h) to con-
centrate the sample and to remove the Percoll. To separate the
luminal (soluble) protein extracts from the granule membrane
protein extracts, granule pellets were diluted in homogeniza-
tion buffer, disrupted with a tip sonicator at one-third power (8
MHz) three times for 30 s on ice, and fractionated by ultracen-
trifugation (100,000 3 g, 1 h, Beckman TLA 120.2 rotor). The
luminal fraction was concentrated to;50ml on a 3-kDamolec-
ular mass cutoff Amicon Ultra 0.5-ml centrifugal filter, whereas
membrane pellets were dissolved in 50 ml of TBS with 2% SDS.
For subsequent glycome analyses, the protein concentration of
total, soluble, and membrane protein fractions of the granules
was determined by BCA assay (Thermo Scientific) using BSA
as standard.
Detection of Lewis antigens by immunoblot and
immunofluorescence
The primary antibodies used were directed against Lex
(mouse monoclonal, clone HI98, Santa Cruz Biotechnology)
and sLex (mouse monoclonal, clone CSLEX-1, BD Biosciences).
For the detection of Lewis antigens by immunoblots, equal
amounts of the protein extracts from the granules were blotted
onto a polyvinylidene difluoride membrane, essentially as
described (53). The membrane was blocked 1 h at room tem-
perature in TBS, 0.1% BSA. Primary antibodies were diluted 1/
500 in TBS, 0.01% Tween 20 and incubated at 4 °C overnight.
Immunodetection was performed using secondary horseradish
peroxidase-coupled rabbit anti-mouse (P0260, Dako, Denmark)
with Clarity Western ECL substrate (170-5061, Bio-Rad). For the
detection of Lewis antigens by immunofluorescence, isolated
polymorphonuclear neutrophils were resuspended in cold PBS at
1.5 million cells/ml and attached to adhesion slides (Marienfeld,
Germany) according to themanufacturer’s instructions. The cells
were then fixed in 3.5% paraformaldehyde in PBS and permeabil-
ized with 1% Triton X-100 for 10 min. After extensive washing,
blocking was performed 30 min, in 0.1% BSA in PBS. Primary
antibodies were diluted 1/50 in 0.1% BSA in PBS and incubated
for 1 h. Immunodetection was performed using secondary goat
anti-mouse IgM Alexa 488 (A-11001, Thermo Fisher Scientific),
diluted 1/300 in 0.1% BSA in PBS, and incubated 1 h. Imaging
was performed with a confocal laser scanning LSM-700 micro-
scope (Zeiss).
Release of N- and O-glycans from neutrophil granule proteins
Purified neutrophil granule (whole) proteins, and the soluble
and membrane protein extracts (;20 mg) were solubilized in
homogenization buffer and reduced using 10 mM DTT in 100
mM ammonium bicarbonate (pH 8.4) for 45 min at 56 °C and
alkylated using 25 mM iodoacetamide in 100 mM ammonium
bicarbonate (pH 8.4) (both final concentration) for 30 min in
the dark at 22 °C. N- and O-glycans from the solubilized pro-
teins were released and processed as previously described (54).
Proteins was then blotted on a primed 0.45-mm polyvinylidene
difluoride membrane and stained with Direct Blue stain solu-
tion. The stained protein spots were excised, blocked with 1%
(w/v) polyvinylpyrrolidone in 50% (v/v) methanol, and washed
withMilliQ water.N-glycans were enzymatically released using
3.5 units of Flavobacterium meningosepticum N-glycosidase F
(Promega) in 20 ml of water for 16 h at 37 °C. The unstable
amino group (-NH2) of the reducing end GlcNAc residues of
N-glycosidase F–released N-glycans were allowed to spontane-
ously convert to hydroxyl groups (-OH) in weak acid using 100
mM ammonium acetate, pH 5, for 1 h at 22 °C to facilitate sub-
sequent quantitative reduction to glycan alditols. Reduction of
the released N-glycans was carried out using 1 M sodium boro-
hydride in 50 mM potassium hydroxide for 3 h at 50 °C. The O-
glycans were then subsequently released by reductive b-elimi-
nation from the peptide:N-glycosidase F enzyme–treated pro-
teins by incubating overnight in 0.5 M sodium borohydride in
50 mM potassium hydroxide. The reduction reaction was
stopped by glacial acetic acid quenching. Dual desalting was
then performed in micro-solid phase extraction formats using
strong cation exchange/C18 (whereN-glycans are not retained)
and PGC (where N-glycans are retained) as stationary phases,
respectively. The desalted N- and O-glycans were eluted from
the PGC–solid phase extraction columns using 40% (v/v) aceto-
nitrile (ACN) containing 0.1% (v/v) aqueous trifluoroacetic
acid (TFA), dried, and dissolved in 10 ml of MilliQ water for N-
glycan analysis. Bovine fetuin carrying sialo-N-glycans were
included as a control glycoprotein to ensure efficient N-glycan
release, clean-up, and LC–MS/MS performance.
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PGC–LC–MS/MS–based N- and O-glycomics
Released N- and O-glycans were analyzed by liquid chroma-
tography–tandem MS (LC–MS/MS) in two different laborato-
ries. Glycans from the total granule protein extracts (nonsepa-
rated) were analyzed on PGC–LC using a 10-cm 3 250-mm
inner-diameter column (in-house), containing 5 mm PGC par-
ticle size (Thermo Scientific, Waltham, MA, USA) connected
to an LTQ- ion trap mass spectrometer (Thermo Scientific).
The N- and O-glycans were eluted using a linear gradient from
0 to 40%ACN in 10mM ammonium bicarbonate over 40min at
a flow rate of 250 ml/min split down to 5–10 ml/min. The sam-
ple injection volume was 3 ml. Electrospray ionization–MS was
performed in negative ion polarity with an electrospray voltage
of 3.5 kV, capillary voltage of 233.0 V, and capillary tempera-
ture of 300 °C. The following scan events were used: MS full
scan (m/z 380–2000) and data-dependent MS/MS scans after
collision-induced dissociation (CID) on precursor ions at a nor-
malized collisional energy of 35%with a minimum signal of 300
counts, isolated width of 2.0m/z, and activation time of 30 ms.
The data were viewed and manually analyzed using Xcalibur
software (version 2.2, Thermo Scientific).
N-Glycans released from the soluble and membrane protein
extracts from each granule were analyzed using capillary LC–
MS/MS (Dionex Ultimate 3000) on an electrospray ionization
linear ion trap mass spectrometer (LTQ Velos Pro, Thermo
Scientific, Melbourne, Australia). The samples were injected
onto a PGC capillary column (Hypercarb KAPPA, 5-mm parti-
cle size, 200 Å pore size, 180-mm inner diameter 3 100-mm
length; Thermo Scientific) kept at 50 °C. Separation of N-gly-
cans was carried out over a linear gradient of 2–32% ACN, 10
mM ammonium bicarbonate for 75 min at a constant flow rate
of 4 ml/min. The sample injection volume was 4 ml. The acqui-
sition range wasm/z 380–2000. The acquisition was performed
in negative ionization polarity with an electrospray voltage of
4.0 kV, capillary voltage of214.9 kV, and capillary temperature
of 310 °C. Data-dependent acquisition was used where the top
nine most abundant precursors in each full scan spectrum were
selected for CID–MS/MS at a normalized collision energy of
35%. A minimum signal of 300 counts was required for MS/
MS. The precursor isolation width wasm/z 1.0, and the activa-
tion time was 10 ms. The mass spectrometer was calibrated
using a tunemix (Thermo Scientific).Mass spectra were viewed
and analyzed using Xcalibur V2.2 (Thermo Scientific).
Structural determination of N- and O-glycans
The monosaccharide compositions and each N- and O-gly-
can structural sequence and linkage were manually analyzed
using monoisotopic mass, CID–MS/MS fragmentation and
absolute and relative retention time on the PGC–LC–MS/MS
data. Monoisotopic molecular masses of the identified glycans,
which were generally within 0.5 Da of the theoretical masses,
were matched against likely mammalianN- andO-glycanmon-
osaccharide compositions using the GlycoMod web tool (https://
web.expasy.org/glycomod/). GlycoWorkBench v2.1 was used to
draw the proposed glycans and to generate in silico glycosidic and
cross-ring fragments to assist in the structural interpretation
based on the obtained CID–MS/MS data. (55).
Characterization of glycans was performed manually using
PGC–LC retention time, monoisotopic precursor mass, and
CID–MS/MS fragmentation patterns combined with the appli-
cation of biosynthetic rules and several aiding software pro-
grams and approaches to enhance the confidence of each
reported glycan structure (33, 56). The CID–MS/MS fragmen-
tation data were compared with data available in UniCarb-DB
(57) and UniCarb-DR (open-access database) and to in silico
fragments generated using GlycoWork Bench software (58, 59).
Further, the presence of diagnostic ions was used to identify
structural motifs within the reported glycans, e.g. sLex, LacNAc
repeats and core fucosylation (23, 60). The absolute and relative
PGC retention behavior of each glycan (recorded in UniCarb-
DB, UniCarb-DR, and Glycostore (https://glycostore.org)) was
used to increase the confidence of the structures identified,
especially for isomers. This includes the relative early elution of
a2,6-sialylated versus a2,3-sialylated isomers (61) and core ver-
sus antennary fucosylation (60). For the larger glycan structures
(.3200 Da) that did not produce high-quality fragment spec-
tral data, we relied on biosynthetic rules of lactosamine exten-
sion and termination of lactosamines by sialylation or Lewis-
type structures. For this reason, some structural ambiguity
(indicated with brackets and open/unannotated glycosidic link-
ages) remained for the large glycan structures.
Statistical analysis
Statistical analysiswas performedusingGraphPadPrismversion
8 software (La Jolla, CA, USA). The quantitative data are expressed
as means6 S.E. and analyzed using two-tailed Student’s t test, and
p values, 0.05were considered statistically significant.
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